Jenny Chaplin
Corporate Officer/Principal at BELLICUM PHARMACEUTICALS, INC.
Profile
Jenny Chaplin is currently the Vice President-Strategic Operations at Bellicum Pharmaceuticals, Inc. She previously worked at Pfizer Inc. She obtained an undergraduate degree from the University of the Witwatersrand.
Jenny Chaplin active positions
| Companies | Position | Start |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-12-31 |
Training of Jenny Chaplin
| University of the Witwatersrand | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Jenny Chaplin
